Salvia has raised over $90 million in total funding and is advancing clinical development with the support of leading investors.
Founders
Hubert Martens, Daniel Schobben, Wim Pollet
Company Description
Salvia BioElectronics is a clinical-stage medical device company pioneering neuromodulation therapy for chronic migraine patients. Their ultra-thin implant targets key nerves involved in migraine, aiming to reduce both the frequency and intensity of attacks.
Market
Chronic migraine treatment
Location
UK
Coinvestors
Innovation Industries, Invest-NL, EIC Fund, Inkef, Panakès Partners, SHS Capital, Dolby Family Ventures, BOM, Thuja Capital